A Study Designed to Compare the Safety and Pharmacokinetics of Intravenously Administered Superoxide Dismutase Mimetic GC4711 and GC4419 in Healthy Volunteers
Clinical trial NCT03194139 · COMPLETED
Trial details
- NCT number
- NCT03194139
- Sponsor
- Galera Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-25
- Primary completion
- 2017-12-24
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.